Text Size

Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison

This study has been completed.
Sponsor:
Collaborator:
Centers for Disease Control and Prevention
Information provided by (Responsible Party):
Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov Identifier:
NCT00739258
First received: August 19, 2008
Last updated: January 20, 2012
Last verified: December 2011
History of Changes
  Purpose

It is difficult to detect the intestinal protozoal infections among the HIV-infected persons or travelers diarrhea by using the traditional microscopy or staining methods. The purpose of this study aimed at finding out the appropriate diagnostic methods and the infection rate of the intestinal protozoa, including the Entamoeba, Cryptosporidium and Giardia among the HIV-infected persons by using the antigen detection method and biological method. The investigators also tried to analyze the associated HIV infection status and sexual transmitted diseases (STD) including Gonorrhea, Chlamydial trachomatis, Syphilis, Genital warts and Herpes simplex virus in this study. The study will collect the blood, urine and stool samples from 200 intravenous drug user (IDU) with HIV-infected in the prisons, 400 intravenous drug user (IDU) without HIV infected and 100 intravenous drug user (IDU) with HIV infected receiving methadone maintenance treatment.


Condition
HIV Infections

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison and Set up the Notional Halfway Home in Union Area of Medical Facility

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:

Estimated Enrollment: 700
Study Start Date: April 2008
Study Completion Date: December 2010
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
HIDU
intravenous drug user (IDU) with HIV infected
IDU
intravenous drug user (IDU) without HIV
MH
persons receiving methadone maintenance treatment

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The samples are obtained from Kaohsiung prison, Kaohsiung women's prison, Pingtung prison and the Kaohsiung Medical University Chung-Ho Memorial Hospital in Kaohsiung, Taiwan.

Criteria

Inclusion Criteria:

  • Clinical diagnosis of HIV
  • Receiving Methadone Maintenance Treatment
  • intravenous drug user (IDU)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00739258

Locations
Taiwan
Kaoshing Medical University Chung-Ho Memorial Hospital
Kaohsiung, Taiwan
Sponsors and Collaborators
Kaohsiung Medical University Chung-Ho Memorial Hospital
Centers for Disease Control and Prevention
  More Information

No publications provided

Responsible Party: Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov Identifier: NCT00739258     History of Changes
Other Study ID Numbers: KMUH-IRB-970077
Study First Received: August 19, 2008
Last Updated: January 20, 2012
Health Authority: Taiwan: Institutional Review Board

Keywords provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:
HIV-infected person
Entamoeba
Cryptosporidium
Giardia
ELISA
PCR
 IDU
Gonorrhea
Chlamydial trachomatis
Syphilis
Genital warts
Herpes simplex virus

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
 Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases

ClinicalTrials.gov processed this record on March 10, 2013